
Quarterly report 2025-Q3
added 11-04-2025
COMPASS Pathways plc EBITDA 2011-2025 | CMPS
Earnings before Interest, Taxes, Depreciation, and Amortization (EBITDA), is an often used measure of a company's profitability. Financial analysts use EBITDA for a number of purposes including calculating simple valuations of a firm, estimating cash flows, and assessing debt servicing capability. The uses for EBITDA in financial analysis are numerous, but in practice should be more restrained. While EBITDA has some useful applications, it should be used with caution, as the problems with EBITDA are abundant and can lead to a number of misguided conclusions.[1]
EBITDA is an important indicator for investors and analysts because it allows them to evaluate a company's operating profit without considering the impact of financial expenses, taxes, or non-cash depreciation and amortization. It provides better comparability between companies in different industries or with different tax conditions.
EBITDA is often used to assess a company's ability to generate cash flow and repay debts. It can also serve as a measure of a company's operational efficiency, as it shows how profitable the core business is, regardless of external factors such as interest or taxes.
However, it is important to note that EBITDA is not an official financial statement measure and can be defined and calculated differently by companies. Therefore, investors and analysts should exercise caution when using EBITDA as an evaluation tool and combine it with other financial metrics and information to get a more complete picture of a company's financial condition.
Annual EBITDA COMPASS Pathways plc
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -178 M | -137 M | -110 M | -83 M | -51.3 M | -21.1 M | -12.5 M | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -12.5 M | -178 M | -84.7 M |
Quarterly EBITDA COMPASS Pathways plc
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | -49.6 M | - | - | - | -38.5 M | - | - | - | -31.7 M | - | -25.4 M | -27.3 M | -25.4 M | - | -21.7 M | -19.4 M | -13.6 M | - | -13.4 M | -17.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -13.4 M | -49.6 M | -25.8 M |
References
- Brockman, C. M., & Russell, J. W. (2012). EBITDA: use it... or lose it?. International Journal of Business, Accounting and Finance, 6(2), 84-93.
EBITDA of other stocks in the Care facilities industry
| Issuer | EBITDA | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Apollo Medical Holdings
AMEH
|
102 M | - | -2.11 % | $ 1.84 B | ||
|
American Shared Hospital Services
AMS
|
3.37 M | $ 2.07 | - | $ 13.4 M | ||
|
Avalon GloboCare Corp.
AVCO
|
-4.75 M | - | 26.45 % | $ 70.6 M | ||
|
Brookdale Senior Living
BKD
|
414 M | $ 11.0 | -0.81 % | $ 2.5 B | ||
|
Мать и Дитя
MDMG
|
8.13 B | - | - | - | ||
|
Amedisys
AMED
|
121 M | - | 0.01 % | $ 3.3 B | ||
|
Chemed Corporation
CHE
|
430 M | $ 431.6 | -1.47 % | $ 6.48 B | ||
|
HCA Healthcare
HCA
|
3.08 B | $ 502.31 | -0.11 % | $ 137 B | ||
|
Healthcare Services Group
HCSG
|
14.6 M | $ 18.79 | -0.27 % | $ 1.39 B | ||
|
Hanger
HNGR
|
105 M | - | - | $ 732 M | ||
|
Encompass Health Corporation
EHC
|
300 M | $ 114.44 | -0.21 % | $ 11.4 B | ||
|
Acadia Healthcare Company
ACHC
|
150 M | $ 16.55 | -1.72 % | $ 1.52 B | ||
|
The Ensign Group
ENSG
|
442 M | $ 182.3 | -0.72 % | $ 10.3 B | ||
|
IMAC Holdings
IMAC
|
-5.48 M | - | -1.77 % | $ 25.4 M | ||
|
Elanco Animal Health Incorporated
ELAN
|
662 M | $ 22.56 | -0.31 % | $ 11.1 B | ||
|
The Joint Corp.
JYNT
|
7.47 M | $ 8.32 | -0.36 % | $ 121 M | ||
|
Concord Medical Services Holdings Limited
CCM
|
-394 M | $ 3.74 | -3.36 % | $ 490 M | ||
|
Community Health Systems
CYH
|
1.03 B | $ 3.65 | 0.28 % | $ 482 M | ||
|
LHC Group
LHCG
|
132 M | - | - | $ 5.27 B | ||
|
Addus HomeCare Corporation
ADUS
|
116 M | $ 119.62 | -1.01 % | $ 2.03 B | ||
|
Fresenius Medical Care AG & Co. KGaA
FMS
|
3.48 B | $ 23.77 | 0.53 % | $ 7.05 B | ||
|
National HealthCare Corporation
NHC
|
128 M | $ 137.97 | 0.49 % | $ 2.12 B | ||
|
AMN Healthcare Services
AMN
|
499 M | $ 16.84 | -0.59 % | $ 660 M | ||
|
Option Care Health
OPCH
|
383 M | $ 30.75 | -0.61 % | $ 5.28 B | ||
|
Oak Street Health
OSH
|
-97 M | - | 0.03 % | $ 9.53 B | ||
|
Aesthetic Medical International Holdings Group Limited
AIH
|
53.3 M | - | 10.96 % | $ 46.2 M | ||
|
Capital Senior Living Corporation
CSU
|
-235 M | - | -2.09 % | $ 216 M | ||
|
Five Star Senior Living Inc.
FVE
|
26.9 M | - | -0.32 % | $ 98.4 M | ||
|
Genesis Healthcare, Inc.
GEN
|
-162 M | - | - | $ 68.1 M | ||
|
Select Medical Holdings Corporation
SEM
|
472 M | $ 15.19 | -0.85 % | $ 1.89 B | ||
|
Surgery Partners
SGRY
|
446 M | $ 16.98 | -0.7 % | $ 2.13 B | ||
|
Sanara MedTech
SMTI
|
-540 K | $ 20.46 | 0.64 % | $ 169 M | ||
|
SunLink Health Systems
SSY
|
-1.04 M | - | 17.98 % | $ 7.81 M | ||
|
New Frontier Health Corporation
NFH
|
354 M | - | 3.54 % | $ 1.5 B | ||
|
DaVita
DVA
|
2.81 B | $ 119.3 | 0.03 % | $ 10.1 B | ||
|
MEDNAX
MD
|
-36.5 M | $ 23.87 | -0.75 % | $ 1.99 B | ||
|
ModivCare
MODV
|
16.7 M | - | -25.23 % | $ 6.12 M | ||
|
Novo Integrated Sciences
NVOS
|
-7.81 M | - | -13.87 % | $ 1.52 M | ||
|
Ontrak
OTRK
|
-17.2 M | - | -11.98 % | $ 1.53 M | ||
|
Phibro Animal Health Corporation
PAHC
|
156 M | $ 40.66 | -0.25 % | $ 1.65 B | ||
|
The Pennant Group
PNTG
|
44.2 M | $ 29.2 | 2.82 % | $ 911 M | ||
|
Regional Health Properties
RHE
|
2.22 M | - | - | $ 5.2 M | ||
|
Tenet Healthcare Corporation
THC
|
6.77 B | $ 216.67 | 0.73 % | $ 21 B | ||
|
Universal Health Services
UHS
|
2.27 B | $ 239.77 | - | $ 16 B | ||
|
U.S. Physical Therapy
USPH
|
81.9 M | $ 73.91 | 0.38 % | $ 1.11 B | ||
|
Tivity Health
TVTY
|
154 M | - | 0.09 % | $ 1.6 B |